* Dispersible tablets, specially designed to disintegrate rapidly in water to give a tasteless suspension for oral ingestion.* Indications / Potential uses: Short-term (maximum 2 weeks) of the following acute conditions:  – Postoperative inflammation and pain, e.g. following dental or orthopaedic surgery.  – Painful post-traumatic inflammatory states, e.g. due to sprains.  – Painful and/or inflammatory gynaecological conditions, e.g. primary dysmenorrhoea or adnexitis.  – As an adjunct in severe painful inflammatory infections of the ear, nose, or throat, e.g. pharyngotonsillitis, otits.  – Gout.  – In keeping with standard therapeutic principles, the underlying disease should be treated with specific therapy, as appropriate.  – Fever alone is not an indication.* Dosage:  # Adults:  – The recommended dosage is 2-3 Anuva dispersible tablets (100-150 mg) daily. In milder cases, as well as for  children over 14 years of age, 2 tablets daily are usually sufficient. The total daily amount should normally be given in  2-3 divided doses.  – In primary dysmenorrhoea the daily dosage is generally 1-3 Anuva dispersible tablets, with individual adjustment.  Initially a dose of 1-2 tablets should be prescribed. If necessary, this may be raised over the course of several  menstrual cycles up to a maximum of 4 tablets daily. Treatment should be started at the onset of the first symptoms  and continued for a few days, depending on the response.  # Children:  – Because of their strength, Anuva dispersible tablets are not recommended for use in children below 14 years of age.  – Anuva drops and Anuva 12.5 mg and 25 mg suppositories are available for use in children.  # Administration:  Anuva dispersible tablets should be taken before meals. The dispersible tablets should be dropped into a glass of water  and the liquid stirred to aid dispersion, then drunk. Since a proportion of the active substance may remain in the glass  after drinking, the glass should be rinsed with a small amount of water, which should also be drunk.  # Contra-indications:  – Peptic ulcer.  – In patients in whom attacks of asthma, urticaria, or acute rhinitis are precipitated by acetylsalicylic acid or by other drugs  with prostaglandin-synthetase inhibiting activity.* Store below 25 degrees C. Protect from moisture and heat.* Produced by: NOVARTIS PHARMA S.A.E. Cairo, under license from: Novartis, Pharma AG., Basle, Switzerland.